These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25179972)

  • 1. Case report: new treatment with Tolvaptan for heart failure after cardiac surgery.
    Sezai A; Iida M; Yoshitake I; Osaka S; Hata H; Shiono M
    Heart Surg Forum; 2014 Aug; 17(4):E198-200. PubMed ID: 25179972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Tolvaptan on Fluid Management After Cardiovascular Surgery Using Cardiopulmonary Bypass.
    Ito H; Mizumoto T; Tempaku H; Fujinaga K; Sawada Y; Shimpo H
    J Cardiothorac Vasc Anesth; 2016 Dec; 30(6):1471-1478. PubMed ID: 27591907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tolvaptan in the early postoperative stage after heart valve surgery: results of the STAR (Study of Tolvaptan for fluid retention AfteR valve surgery) trial.
    Nishi H; Toda K; Miyagawa S; Yoshikawa Y; Fukushima S; Kawamura M; Yoshioka D; Saito T; Ueno T; Kuratani T; Sawa Y
    Surg Today; 2015 Dec; 45(12):1542-51. PubMed ID: 26411431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the oral vasopressin receptor antagonist tolvaptan on congestive cardiac failure in a child with restrictive cardiomyopathy.
    Horibata Y; Murakami T; Niwa K
    Cardiol Young; 2014 Feb; 24(1):155-7. PubMed ID: 23388069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trials.
    Miyazaki T; Fujiki H; Yamamura Y; Nakamura S; Mori T
    Cardiovasc Drug Rev; 2007; 25(1):1-13. PubMed ID: 17445084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
    Gheorghiade M; Niazi I; Ouyang J; Czerwiec F; Kambayashi J; Zampino M; Orlandi C;
    Circulation; 2003 Jun; 107(21):2690-6. PubMed ID: 12742979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hypertension predicts adverse cardiac events after restrictive mitral annuloplasty for severe functional mitral regurgitation.
    Kainuma S; Taniguchi K; Toda K; Funatsu T; Kondoh H; Nishino M; Daimon T; Sawa Y
    J Thorac Cardiovasc Surg; 2011 Oct; 142(4):783-92. PubMed ID: 21397266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mitral valve replacement for hypertrophic obstructive cardiomyopathy with repeated heart failure; report of a case].
    Okada H; Nishida M; Takahashi M
    Kyobu Geka; 2007 Mar; 60(3):242-4. PubMed ID: 17352143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of tolvaptan in heart failure patients with volume overload.
    Kinugawa K; Sato N; Inomata T; Shimakawa T; Iwatake N; Mizuguchi K
    Circ J; 2014; 78(4):844-52. PubMed ID: 24670835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin V2 receptor antagonist tolvaptan is effective in heart failure patients with reduced left ventricular systolic function and low blood pressure.
    Suzuki S; Yoshihisa A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Abe Y; Saito T; Ohwada T; Suzuki H; Saitoh S; Kubota I; Takeishi Y;
    Int Heart J; 2015; 56(2):213-8. PubMed ID: 25740399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical ventricular restoration combined with mitral valve procedure for endstage ischemic cardiomyopathy.
    Suma H; Tanabe H; Uejima T; Isomura T; Horii T
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):280-4; discussion 284-5. PubMed ID: 19394851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identical tricuspid ring sizing in simultaneous functional tricuspid and mitral valve repair: A simple and effective strategy.
    Huffman LC; Nelson JS; Lehman AN; Krajacic MC; Bolling SF
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):611-4. PubMed ID: 23477691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment.
    Vaduganathan M; Gheorghiade M; Pang PS; Konstam MA; Zannad F; Swedberg K; Grinfeld L; Burnett JC; Krasa HB; Zimmer C; Blair J; Ouyang J; Maggioni AP;
    J Cardiovasc Med (Hagerstown); 2012 Jul; 13(7):415-22. PubMed ID: 22673023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction.
    Udelson JE; McGrew FA; Flores E; Ibrahim H; Katz S; Koshkarian G; O'Brien T; Kronenberg MW; Zimmer C; Orlandi C; Konstam MA
    J Am Coll Cardiol; 2007 Jun; 49(22):2151-9. PubMed ID: 17543634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of postoperative noradrenaline need by nitric oxide inhibition using L-NMMA.
    Franco-Cereceda A; Holm P; Bredin F; Adding C
    Eur J Heart Fail; 2005 Dec; 7(7):1180-2. PubMed ID: 15916920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective mechanical cardiac support in a child in the absence of a mitral valve.
    Trezzi M; Bradley SM; Savage AJ; Kavarana MN
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):e61-2. PubMed ID: 24071467
    [No Abstract]   [Full Text] [Related]  

  • 18. [A surgical case of quadricuspid aortic valve associated aortic regurgitation and severe mitral regurgitation due to infective endocarditis].
    Asami H; Asano H; Handa N; Nakamura S; Ogiwara M; Ueda K; Kyo S; Yokote Y; Omoto R
    Kyobu Geka; 1998 Mar; 51(3):216-9. PubMed ID: 9528228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitral valve surgery for functional mitral regurgitation in patients with chronic heart failure--update of the results.
    Calafiore AM; Iacò AL; Tash A; Abukudair W; Di Mauro M
    Thorac Cardiovasc Surg; 2010 Apr; 58(3):131-5. PubMed ID: 20383826
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of untreated mild-to-moderate mitral regurgitation at the time of isolated aortic valve replacement on late adverse outcomes.
    Takeda K; Matsumiya G; Sakaguchi T; Miyagawa S; Yamauchi T; Shudo Y; Izutani H; Sawa Y
    Eur J Cardiothorac Surg; 2010 May; 37(5):1033-8. PubMed ID: 20362456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.